Hygeia Healthcare Holdings Co., Limited (06078) disclosed that as of February 25, 2026, the company had repurchased 358,800 of its ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 13.84 to HKD 14.02 per share, with an aggregate consideration of HKD 5.00 million. Following the repurchase, the total number of issued shares remained 618,499,000, of which 616,116,600 shares were in circulation and 2,382,400 were held as treasury shares.

According to the announcement, the repurchase accounted for 0.0582% of the number of issued shares (excluding treasury shares) before the transaction. The repurchase mandate, approved on June 27, 2025, authorized up to 61,849,900 shares for buybacks. As of the date of this disclosure, 2,382,400 shares had been repurchased under that mandate. The company noted a 30-day moratorium on new share issuances or treasury share sales following this repurchase, ending on March 27, 2026.